Immunodiagnostic : Director/PDMR Shareholding

Immunodiagnostic Systems Holdings plc

Director Dealing

21 February 2020

Immunodiagnostic Systems Holdings plc (IDH.L) ('IDS' or the 'Company'), a specialist producer of manual and automated diagnostic testing kits and instrumentation for the clinical and research markets,was advised that today, Paul Martin, Group Finance Director, acquired 3,000 ordinary shares of 2p each ('Ordinary Shares') in the Company at an average price of £2.20 per Ordinary Share.

Following these purchases, Mr Martin is interested in 22,350 Ordinary Shares, 0.08% of the issued share capital of the Company.

For further information:

Immunodiagnostic Systems Holdings plc	Tel : [phone]
Paul Martin, Group Finance Director
Peel Hunt LLP	Tel : [phone]
James Steel
Oliver Jackson

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities / person closely associated
a.	Name	Paul Martin
2.	Reason for the notification
a.	Position/status	Group Finance Director
b.	Initial notification /Amendment	Initial
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Immunodiagnostic Systems Holdings plc
b.	LEI	213800HZMYTD4NGF4L78
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the Financial instrument, type of instrument Identification code	Ordinary shares of 2p each in Immunodiagnostic Systems Holdings plc Ordinary shares GB00B01YZ052
b.	Nature of the transaction	Purchase
c.	Price(s) and volume(s)	Price(s) Volume(s) £2.20 3,000
d.	Aggregated information · Aggregated volume · Price	N/A
e.	Date of the transaction	2020-02-21
f.	Place of the transaction	London Stock Exchange, AIM